Paul Rennie
Chief Executive Officer at PARADIGM BIOPHARMACEUTICALS LIMITED
Net worth: 5 M $ as of 2024-03-30
Profile
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., which was founded in 2014.
He currently holds the position of Executive Chairman & Managing Director at the company.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd.
as Non-Executive Chairman from 2021 to 2023, Stiefel Research Australia Pty Ltd.
as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd.
as Manager-Business Development, Mesoblast Ltd.
as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd.
as Manager-Sales & Marketing.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-28 | 20,678,805 ( 6.67% ) | 5 M $ | 2024-03-30 |
Paul Rennie active positions
| Companies | Position | Start |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Chief Executive Officer | 2022-11-21 |
Former positions of Paul Rennie
| Companies | Position | End |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Chief Executive Officer | 2023-09-10 |
Stiefel Research Australia Pty Ltd.
 Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The private company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Corporate Officer/Principal | - |
| MERCK KGAA | Sales & Marketing | - |
| Roche Diagnostics Australia Pty Ltd. | Sales & Marketing | - |
| MESOBLAST LIMITED | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Bonlac Foods Ltd.
 Bonlac Foods Ltd. Food DistributorsDistribution Services Bonlac Foods Ltd. manufactures dairy products and ingredients for domestic and international customers. The firm products include fresh & UTH milk, milk powders, cheese, spreads, fruit juice, sport drinks, and yoghurts. The company is located in Melbourne, Australia. | Distribution Services |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Part of GSK Plc, Stiefel Research Australia Pty Ltd. is an Australian company that develops delivery systems for new dermatology products. The private company is based in Rowville, Australia. Stiefel Research Australia was acquired by Connetics Corp. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million. | Health Technology |
| Roche Diagnostics Australia Pty Ltd. | |
| Paradigm Biopharmaceuticals Ltd. |
- Stock Market
- Insiders
- Paul Rennie
